GTB-7550

N/A

Report date: 2024/11/29 14:39:31

Base Information

Drug NameGTB-7550

Drug Alias NameGTB-7550CAM-161519

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-chain FV antibody fragment (scFv)Biologics > Protein drugs > Recombinant protein > Fusion protein +[4]

Mechanisms of ActionAnti-CD19Interleukin-15 receptors agonistsFCGR3A (CD16a) NK-cell engagers

TargetsB-lymphocyte antigen CD19Interleukin-15 receptorsLow affinity immunoglobulin gamma Fc region receptor III-A

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Minnesota Gt Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesGt Biopharma Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A